Back
ESC Professional Premium Access

Regnase-1 overexpression as a novel gene therapy approach for pulmonary hypertension

Session: New insights and therapeutic options in pulmonary arterial hypertension
Topic: Hypertension, Pulmonary Hypertension
Speaker: Doctor A. Remes (Kiel, DE)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Anca Remes

Christian-Albrechts-University Kiel, Kiel (Germany)
0 follower

6 more presentations in this session

Focused ultrasound stimulation of the inflammatory reflex at the spleen ameliorates pulmonary arterial hypertension in rodents

Speaker: Doctor S. Zafeiropoulos (Manhasset, US)

Access
Abstract
Slides
Thumbnail

A miRNA derived from the 17/92 cluster is a novel player in programming pulmonary hypertension in response to gestational hypoxia via NADPH oxidases and the mTOR pathway

Speaker: Ms Y. Qin (Munich, DE)

Access
Abstract
Slides
Thumbnail

AD-9308 ameliorates the impacts of 4-HNE on the progress of pulmonary arterial hypertension in aldehyde dehydrogenase 2*1*2 knock-in mice

Speaker: Mr Y. Chou (New Taipei, TW)

Access
Abstract
Slides
Thumbnail

Hemodynamic pulmonary response to exercise according to different resting pulmonary hypertension thresholds in chronic thromboembolic pulmonary disease

Speaker: Mr S. Huertas Nieto (Santa Cruz de Tenerife, ES)

Access
Abstract
Slides
Thumbnail

Transcriptomic profiling reveals connection to lung autonomic nervous system dysfunction and inflammation in pulmonary artery hypertension rats

Speaker: Doctor T. Tan (Wuhan, CN)

Access
Abstract
Slides
Thumbnail

Access the full session

New insights and therapeutic options in pulmonary arterial hypertension

Speakers: Doctor A. Remes, Doctor S. Zafeiropoulos, Ms Y. Qin, Mr Y. Chou, Mr S. Huertas Nieto...
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb